This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Karil Abrahamson: Innovator in Gene Therapy
Introduction
Karil Abrahamson is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of gene therapy through her innovative work. Her research focuses on the development of adenoviral vectors, which are crucial for therapeutic applications.
Latest Patents
Karil holds a patent for "Non-group C adenoviral vectors." This invention provides replication-deficient non-group C adenoviral vectors. The patent also outlines a therapeutic method that relates to gene therapy and vaccination, utilizing these vectors to incorporate foreign nucleic acids.
Career Highlights
Karil Abrahamson is affiliated with Cornell University, where she continues her research and development in the field of gene therapy. Her work has garnered attention for its potential applications in medical treatments.
Collaborations
Some of her notable coworkers include Erik S Falck-Pedersen and Ronald G Crystal. Their collaborative efforts contribute to advancing research in gene therapy and related fields.
Conclusion
Karil Abrahamson is a key figure in the innovation of gene therapy, with her patent on adenoviral vectors showcasing her contributions to medical science. Her work at Cornell University continues to influence the future of therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile